Noelle Hutchins
Senior Associate at Omega Funds
Boston, Massachusetts
Overview
Work Experience
Senior Associate
2023 - Current
Associate
2020 - 2023
Omega Funds global life sciences-based investment firm that specializes in direct secondary transactions.
Board Observer
2022
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Raised $295,500,000.00 from Tekla Capital Management, Fidelity, Ally Bridge Group, Invus, AyurMaya, Longitude Capital, Piper Heartland Healthcare Capital, T. Rowe Price, Omega Funds and Velosity Capital.
Member
2019 - 2023
Pipeline Angels is changing the face of angel investing and creating capital for women and non-binary femme social entrepreneurs. Members serve as the friends and family round for entrepreneurs who may not already have support at that critical stage.
Pipeline Angels is changing the face of angel investing and creating capital for women and non-binary femme social entrepreneurs.
Life Science Consultant
2015 - 2020
Evaluated and determined the commercial suitability and intellectual property of 60+ early-stage biomedical technologies for investment and out-licensing opportunities
TreMonti provides advice and assistance to universities, governments and companies, regarding intellectual asset management issues.
Ideation Lead, Emerging Strategies and Ventures
2018 - 2020
Science and Medicine Advisor
2016 - 2018
Go Red For Women provides women's care services.
Postdoctoral Research Scientist
2014 - 2016
Center for the Genetics of Host Defense
Postdoctoral Research Scientist
2013 - 2014
Department of Surgery, Division of Surgical Research
Rhode Island Hospital operates as a hospital in Rhode Island. It offers cancer care, cardiac care, clinical coordinating, colorectal care,
Raised $2,250,000.00 from American Heart Association, Office for Victims of Crime, National Institutes of Health and CareFusion.
Graduate Student
2007 - 2013
Department of Surgery, Division of Surgical Research (Pathobiology Graduate Program)
Advanced Scientist
2007 - 2007
Animal Health Division
Scynexis engages in drug discovery, development and manufacturing projects in various areas.
Raised $279,349,343.00 from Silicon Valley Bank and Hercules Capital.
Scientist
2006 - 2007
Department of Gene Expression and Protein Biochemistry (GEPB)